Mukul Agrawal stock hits 5% upper circuit after reporting ₹23.4 Cr profit compared to ₹77 Cr loss previous yr
News by Aliceblue News Desk
13 Aug 2025
Introduction
Leading pharma firm posted a Q1 FY26 net profit of ₹23.41 crore, down 45.64% QoQ, reviving from a ₹77.57 crore loss YoY, with revenue at ₹708.05 crore and total income at ₹732.80 crore.
Also Read: 2 Stocks to watch after companies declare 1:1 bonus shares
Share price movement of Dishman Carbogen
On August 13, 2025, Dishman Carbogen Amcis Ltd opened at ₹252.00, up 3.75% from its previous close of ₹242.90. The stock reached a high of ₹255.00 (4.98%) and a low of ₹250.00. By 9:54 AM, it traded at ₹255.00, a 4.98% increase, with a market cap of ₹3,997.97 crore.
Dishman Carbogen Amcis Q1 FY26 Financial Performance
Dishman Carbogen Amcis Limited reported a net profit of ₹23.41 crore in Q1 FY26, down 45.64% QoQ from ₹43.09 crore but reversing a ₹77.57 crore loss in Q1 FY25.
Revenue from operations stood at ₹708.05 crore in Q1 FY26, marginally down 1.16% QoQ from ₹716.34 crore but up 35.19% YoY compared to ₹523.78 crore in the same quarter last year.
Total income for Q1 FY26 reached ₹732.80 crore, reflecting a 1.17% QoQ increase from ₹724.31 crore and a 39.50% YoY rise from ₹525.21 crore in Q1 FY25.
Ace investor holding in Dishman Carbogen
Mukul Mahavir Agrawal holds a 5.50% stake in Dishman Carbogen Amcis Ltd, owning 8,617,000 shares valued at ₹219.6 crore.
Stock performance of Dishman Carbogen for Period of 1 week, 6 months, and 1 year
Dishman Carbogen Amcis Ltd delivered a 0.35% return over the past week, gaining 19.6% in the past six months. The stock rose 24.1% over the past year.
Also Read: Dolly Khanna stock trading at discount of more than 20% to keep an eye on
Shareholding pattern of Dishman Carbogen
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
| Promoter | 59.30% | 59.30% | 59.30% |
| FII | 9.90% | 9.50% | 8.80% |
| DII | 1.30% | 1.30% | 1.40% |
| Public | 29.50% | 29.90% | 30.50% |
About Dishman Carbogen
Dishman Carbogen Amcis Ltd (NSE: DCAL) engages in Contract Research and Manufacturing Services, producing specialty chemicals, vitamins, and disinfectants, with operations spanning Switzerland, UK, Europe, China, and other global markets.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Why is Dishman Carbogen Amcis Ltd share price going up today?
A: The company reported a Q1 FY26 net profit of ₹23.41 crore, reversing a ₹77.57 crore loss last year.
Q: What does Dishman Carbogen Amcis Ltd specialize in?
A: The company engages in CRAMS, and manufactures specialty chemicals, vitamins, disinfectants, and other marketable molecules for global markets.
Q: How much stake does Mukul Mahavir Agrawal hold in Dishman Carbogen Amcis Ltd stock?
A: Mukul Mahavir Agrawal holds a 5.50% stake, owning 8,617,000 shares valued at ₹219.6 crore.
News Author
Aliceblue News Desk
